Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin

The aim of this study was to characterize the treatment response and tolerability of sofosbuvir plus ribavirin therapies in Japanese patients infected with hepatitis C virus (HCV) genotype (GT)-2. This retrospective study analyzed 114 Japanese HCV GT-2 patients treated for 12 weeks with 400 mg of so...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Nakamura, Masato, Yasui, Shin, Haga, Yuki, Tawada, Akinobu, Suzuki, Eiichiro, Ooka, Yoshihiko, Takahashi, Koji, Sasaki, Reina, Wu, Shuang, Nakamoto, Shingo, Arai, Makoto, Imazeki, Fumio, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485477/
https://www.ncbi.nlm.nih.gov/pubmed/28486403
http://dx.doi.org/10.3390/biology6020030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485477/
https://www.ncbi.nlm.nih.gov/pubmed/28486403
http://dx.doi.org/10.3390/biology6020030

Ejemplares similares